ESPNJalen Hurts' blood clot diagnosis explained: What it means for the QBPunchFasoranti stood for justice, true federalism — Tunji-OjoThe Jerusalem PostIDF was not planning to strike Iran on Oct. 10 despite reports of attack blocked by TrumpDaily MaverickINTERVIEW: New EU envoy red-flags rigid BEE, SA’s Ukraine ‘double standard’, but hails ‘deeper’ tiesBollywood HungamaSaif Ali Khan begins shooting for Ritesh Batra’s period drama in Mumbai; details of new collaboration remain under wrapsUN NewsWHO supports Nigeria after first Ebola case confirmedInquirerIligan eyes modern waste facility to reduce landfill wasteZDF heuteEntdecken Sie das ZDF-NachrichtenstudioCollider38 Years Later, This 'Star Trek: The Next Generation' Episode Marked the End of an EraRMF24Przełom w sprawie wojskowego Schengen. Zielone światło dla zasady pięciu dniTagesschauHäuser sollen besser gegen Naturgefahren versichert werdenFrance 24Macron says world leaders have made 'stupid' comments on France riots based on fake AI videos
The Daily Newsstand · Free, Always
Wednesday, October 21, 2026

Thermo Fisher Scientific Non-GAAP EPS of $6.68 beats by $0.28, revenue of $12.14B beats by $190M

Translate
  • Thermo Fisher Scientific press release (TMO): Q3 Non-GAAP EPS of $6.68 beats by $0.28.
  • Revenue of $12.14B (+9.2% Y/Y) beats by $190M.
  • Revenue for the third quarter of 2026 grew 9% to $12.14 billion, versus $11.12 billion in the same quarter of 2025. Organic revenue growth was 6%.
  • The company will provide updated 2026 financial guidance during its earnings conference call this morning at 7:00 a.m. Eastern Time.
View the original on Seeking Alpha →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.